<DOC>
	<DOCNO>NCT02063139</DOCNO>
	<brief_summary>Aim study investigate short-term growth child asthma age 5-11 year treatment fluticasone propionate / formoterol spray ( flutiform® ) 200/20 microgram per day</brief_summary>
	<brief_title>Knemometry Study Compare Systemic Safety Flutiform pMDI , Fluticasone pMDI Beclometasone Autohaler Paediatric Subjects Aged 5 Less Than 12 Years .</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Inclusion Criteria Subjects include study meet follow criterion : 1 . Male Female subject 5 &lt; 12 year old . Female subject must premenarche eligible . 2 . Subjects must preadolescent without sign puberty ( acc . Tanner scale ) . 3 . Subjects normal range age height weight . Weight height measurement fall within percentile range 397 % normal value age accord Danish growth chart . 4 . Known history mild intermittent persistent reversible asthma ≥ 3 month prior screen visit . 5 . Require : 1. inhaled SABA therapy ( e.g . Bricanyl Turbuhaler ) require basis , and/or 2 . Regular nonICS controller medication asthma ( e.g. , cromones leukotriene receptor antagonist ) stable dose ≥ 3 month prior screen visit . 6 . No ICS &gt; 2 week prior screen visit . 7 . Demonstrates adequate spirometry technique able use home PEFR meter . 8 . Demonstrated FEV1 ≥ 80 % predict value visit 1following appropriate withholding asthma medication ( applicable ) ( SABA use within 6 hour PFT ) . 9 . Demonstrated satisfactory technique use pMDI plus spacer Autohaler device . 10 . Must continent urine willing perform ( parental/guardian help ) overnight urine collection . 11 . Willing able complete morning even PEFR measure help parent guardian , necessary , attend study visit . 12 . Willing able substitute prestudy prescribe inhaled asthma medication entire duration study study medication . 13 . Written inform consent obtain per national law . Inclusion Criteria require follow runin : 14 . FEV1 within ≤20 % visit 1 value follow appropriate withhold rescue medication ( salbutamol Airomir Autohaler use within 6 hour PFT ) . Rescue medication use ≤2 day last 7 day run period . Exclusion Criteria Subjects exclude study meet follow criterion : 1 . Require medication inhaled SABAs and/or regular nonICS controller medication ( e.g. , cromones leukotriene receptor antagonist ) maintain asthma control . 2 . ICS use within ≤ 2 week prior screen visit . 3 . Any asthma exacerbation severity least 3 month prior screen visit . 4 . Any fracture leg measure knemometry ≤6 month prior screen visit . 5 . Any metabolic disorder disease may impact normal growth pattern . 6 . Near fatal lifethreatening asthma within past year . 7 . Hospitalisation emergency visit asthma within past 6 month . 8 . History oral injectable corticosteroid medication ≤3 month prior screen visit . 9 . Evidence clinically unstable disease , determine medical history , clinical laboratory test , physical examination , Investigator 's opinion , preclude entry study . `` Clinically significant '' define disease , opinion Investigator , would put subject risk study participation , would affect outcome study . 10 . No major surgery require general anesthesia least 3 month prior screen visit . 11 . No febrile illness temperature &gt; 39°C within week screen visit . 12 . In Investigator 's opinion clinically significant upper low respiratory infection within 4 week prior screen visit . 13 . Significant , nonreversible active pulmonary disease ( e.g . cystic fibrosis , bronchiectasis , tuberculosis ) . 14 . Subjects take β block agent , tricyclic antidepressant , monoamine oxidase inhibitor , astemizole ( Hismanal ) , quinidine type antiarrythmics , potent CYP 3A4 inhibitor ketoconazole within 1 week prior screen visit . 15 . Current use medication , allow protocol . 16 . Current evidence hypersensitivity idiosyncratic reaction test medication component . 17 . Receipt Investigational medicinal product within 30 day screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Knemometry</keyword>
</DOC>